13th International Conference on Biologics and Biosimilars
Elixsys, Inc., USA
Himabindu Gaddipati is a medical oncologist based in San Diego, CA. Her varied background has provided her with a comprehensive understanding of the biopharma lifecycle encompassing basic research, product development, regulatory and Intellectual property and practical translational into the clinical realm. Following medical school, she pursued Internal Medicine residency followed by fellowships in Genetics and Molecular Biology from the University of Pennsylvania and Hematology/Oncology from University Hospitals/Case Western Reserve. She served as a visiting scientist at the Wistar Research Institute. She gained valuable insight about the regulatory requirements for marketing approval of drugs as a reviewer in the division of oncology at the US FDA. At the National Cancer Institute, she served as an analyst for the Federal Small Business Innovation Research (SBIR Program) and also completed a certificate program in Technology Transfer. She completed her Master’s degree in Business and Technology Management from the Wharton School of Business. She is currently the co-chair for the Biocom oncology group, a network of more than 120 organizations including hospitals, research institutions, companies and foundations engaged in cancer-related activities in Southern California. Her company Elixsys is committed to facilitating engagement between diverse stakeholders who are engaged in oncology product discovery, development, and commercialization.